198 related articles for article (PubMed ID: 20622742)
1. Cisplatin-induced renal salt wasting syndrome.
Hamdi T; Latta S; Jallad B; Kheir F; Alhosaini MN; Patel A
South Med J; 2010 Aug; 103(8):793-9. PubMed ID: 20622742
[TBL] [Abstract][Full Text] [Related]
2. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer.
Iyer AV; Krasnow SH; Dufour DR; Arcenas AS
Clin Lung Cancer; 2003 Nov; 5(3):187-9. PubMed ID: 14667276
[TBL] [Abstract][Full Text] [Related]
3. Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia: case report.
Cao L; Joshi P; Sumoza D
Am J Clin Oncol; 2002 Aug; 25(4):344-6. PubMed ID: 12151962
[TBL] [Abstract][Full Text] [Related]
4. [A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy].
Matsumura E; Oshiro Y; Miyagi R; Kimura R; Ashimine S; Machida N; Miyazato M; Saito S
Hinyokika Kiyo; 2012 Aug; 58(8):425-9. PubMed ID: 23052267
[TBL] [Abstract][Full Text] [Related]
5. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
Abdelghani L; Modha K; Albaddawi E; Subramanian S
J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
[No Abstract] [Full Text] [Related]
6. [Hyponatremia with cisplatin administration in head and neck cancer patients].
Yajima Y; Fujii M; Tokumaru Y; Habu N
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2861-5. PubMed ID: 21160261
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Severe Hyponatremia Caused by Renal Salt Wasting Syndrome in Oropharyngeal Cancer].
Fujikawa T; Shirakura S; Hatanaka A; Okano W; Tokumaru T; Yamada M; Saito Y; Beppu T
Nihon Jibiinkoka Gakkai Kaiho; 2015 Aug; 118(8):1046-52. PubMed ID: 26548098
[TBL] [Abstract][Full Text] [Related]
8. [Renal salt-wasting syndrome progressing to severe hyponatremia after chemotherapy--a case report].
Suzuki H; Hirashima T; Kobayashi M; Sasada S; Okamoto N; Morishita N; Tamiya M; Matsui K; Kusunoki Y; Kawase I
Gan To Kagaku Ryoho; 2010 Mar; 37(3):543-6. PubMed ID: 20332701
[TBL] [Abstract][Full Text] [Related]
9. Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed.
Rivkees SA
Curr Opin Pediatr; 2008 Aug; 20(4):448-52. PubMed ID: 18622203
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate antidiuretic syndrome hypersecretion after a single dose of cisplatin.
Atas E; Kesik V; Karaoglu A; Kalkan G
J Cancer Res Ther; 2015; 11(4):1032. PubMed ID: 26881621
[TBL] [Abstract][Full Text] [Related]
11. Central Diabetes Insipidus and Cisplatin-Induced Renal Salt Wasting Syndrome: A Challenging Combination.
Cortina G; Hansford JR; Duke T
Pediatr Blood Cancer; 2016 May; 63(5):925-7. PubMed ID: 26928867
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia and renal sodium wasting in patients receiving cisplatinum.
Vassal G; Rubie H; Kalifa C; Hartmann O; Lemerle J
Pediatr Hematol Oncol; 1987; 4(4):337-44. PubMed ID: 3152940
[TBL] [Abstract][Full Text] [Related]
13. [Renal salt wasting syndrome induced by Cisplatin: a case report].
Taniguchi H; Amari Y; Oka H; Kawakita S; Murota T
Hinyokika Kiyo; 2012 Feb; 58(2):97-100. PubMed ID: 22450837
[TBL] [Abstract][Full Text] [Related]
14. Alternating syndrome of inappropriate secretion of antidiuretic hormone and cerebral salt wasting in an infant with brain tumor.
Kaneko K; Noda Y; Yoshimura K
J Pediatr Hematol Oncol; 2014 Apr; 36(3):254-5. PubMed ID: 23171995
[No Abstract] [Full Text] [Related]
15. [Hyponatremia during treatment with cisplatin].
Peyrade F; Taillan B; Lebrun C; Bendini JC; Passerron C; Dujardin P
Presse Med; 1997 Oct; 26(32):1523-5. PubMed ID: 9435831
[TBL] [Abstract][Full Text] [Related]
16. Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer.
Turner N; Stewart J; Barnett F; White S
Asia Pac J Clin Oncol; 2012 Sep; 8(3):e9-e11. PubMed ID: 22897880
[TBL] [Abstract][Full Text] [Related]
17. [Severe Hyponatremia after Cisplatin-Based Chemotherapy : Two Case Reports].
Ohtaka M; Hattori Y; Kumano Y; Maeda Y; Kondo T; Mochizuki T; Kawahara T; Teranishi J; Miyoshi Y; Yumura Y; Uemura H
Hinyokika Kiyo; 2016 Jul; 62(7):361-6. PubMed ID: 27569354
[TBL] [Abstract][Full Text] [Related]
18. Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin.
Shimada A; Takeuchi H; Fukuda K; Suda K; Nakamura R; Wada N; Kawakubo H; Kitagawa Y
Esophagus; 2018 Oct; 15(4):209-216. PubMed ID: 30225740
[TBL] [Abstract][Full Text] [Related]
19. The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
Kusuki M; Iguchi H; Nakamura A; Nishiura H; Kanazawa A; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):74-7. PubMed ID: 15513517
[TBL] [Abstract][Full Text] [Related]
20. Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
Hinai Y; Motoyama S; Niioka T; Miura M
J Clin Pharm Ther; 2013 Dec; 38(6):498-503. PubMed ID: 24102360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
